Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer

Chung-Ang University100 enrolled

Overview

The technique of sentinel lymph node mapping in patients with colon cancer varies among reports, and the optimal method remain to be established. The purpose of this study was to determine the optimal injection technique for sentinel lymph node mapping for colon cancer.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Enrollment

100

Conditions

Sentinel Lymph Node Biopsy Colon Cancer

Interventions

Intraoperative injection (in vivo)PROCEDURE

Intraoperative injection

Postoperative injection (ex vivo)PROCEDURE

postoperative injection

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Stage I - III colon cancer patients Exclusion Criteria: * cancer located at the low rectum which were located within 10 cm of the dentate, recurrent or metastatic colon carcinoma, adjacent organ invasion tumor, prior chemotherapy or radiation, cancer with intestinal obstruction, past intestinal surgery

Locations (1)

Department of Surgery, Chung-Ang university Hospital

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

Accuracy & sensitivity of sentinel lymph node mapping

Time frame: After confirmed pathological report

Central Contacts

In-Taik Chang, M.D., Ph.D.

CONTACT

82-2-6299-1562 caumed5@naver.com

Jun Seok Park, M.D.

CONTACT

82-2-6299-1548 doctorsupreme@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.